The House Appropriations Committee approved a $2.5 billion increase for NIH in fiscal year 2023, as part of a June 30 markup of the Labor, Health and Human Services, Education, and Related Agencies spending bill.
The House of Representatives on June 22 voted 336-85 to pass legislation that would establish the authorities of the Advanced Research Projects Agency-Health (ARPA-H), President Joe Biden’s proposed high-risk, high-reward biomedical research agency.
The Committee on Energy and Commerce passed a bill May 18 that would authorize the establishment of the Advanced Research Project Agency for Health as an independent agency within HHS.
The same House appropriators who, with bipartisan resolve, oversaw years of dramatic funding increases for NIH expressed equally bipartisan misgivings about President Joe Biden’s proposal to boost funding for the Advanced Research Projects Agency for Health while giving NIH a meager raise—and cutting funds for NCI.
Before any strategy can be formulated for next year’s appropriations, cancer groups must confront the formidable challenge of figuring out how much of President Joe Biden’s vision for cancer research is realistic.
After nearly five years in the federal government—at both NCI and FDA—Ned Sharpless is stepping down from his position as NCI director.
In a move that appears to prioritize biomedical engineering over cancer research, President Joe Biden’s proposal for fiscal year 2023 cuts NCI funding by $199 million, a 2.9% percent cut from the current year’s level.
Worry not, because support for cancer research remains strong, NCI Director Ned Sharpless said, even as the institute stalls in its attempts to increase paylines in fiscal year 2022 and as the White House requests a nearly $200 million cutto the FY23 NCI budget.
Changes at Mission Control notwithstanding, the new Cancer Moonshot is ready for liftoff, says Danielle Carnival, coordinator of the White House cancer initiative.
On Feb. 1, as President Joe Biden was preparing to fire up the Cancer Moonshot, Eric Lander was the scientist in charge of mission control.
